Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Givinostat for Duchenne muscular dystrophy	Givinostat	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2023	View \| Download
Giroctocogene fitelparvovec for haemophilia A	Giroctocogene fitelparvovec	Haemophilia A	Haematology	2023	View \| Download
Giredestrant with palbociclib for previously untreated advanced or metastatic breast cancer	Giredestrant , Givosiran (ALN-AS1) , Palbociclib	Breast cancer	Breast Cancer	2022	View \| Download
Gilteritinib maintenance therapy for FLT3-ITD mutated acute myeloid leukaemia	Gilteritinib (ASP2215; Xospata; gilteritinib fumarate)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2022	View \| Download
Gilteritinib for Relapsed or Refractory Acute Myeloid Leukaemia (AML) with an FLT3 Mutation – Second Line	Gilteritinib (ASP2215; Xospata; gilteritinib fumarate)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2018	View \| Download
Gefapixant for chronic refractory cough – First line	Gefapixant (MK-7264)	Idiopathic chronic cough	Respiratory System	2020	View \| Download
Garetosmab for preventing abnormal bone formation in fibrodysplasia ossificans progressiva	Garetosmab (REGN2477)	Fibrodysplasia ossificans progressiva	Musculoskeletal System	2020	View \| Download
Garadacimab for preventing attacks of hereditary angioedema	Garadacimab	Hereditary angioedema (HAE)	Genetic Disorders , Immunology	2023	View \| Download
Gantenerumab for Alzheimer’s disease	Gantenerumab	Alzheimer's disease	Neurology	2022	View \| Download
Galcanezumab for the prophylaxis of episodic and chronic migraine	Galcanezumab (Emgality; LY-2951742)	Migraine	Neurology	2017	View \| Download